Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Nov. 18, 2026

Allarity Therapeutics Granted U.S. Patent for Stenoparib’s Clinical Dosing Regimen, with Protection Into 2045

GlobeNewswire, Inc.

fallback image
Nov. 18, 2026

Zealand Pharma announces initiation of the Phase 2 ZYNERGY trial of petrelintide co-administered with enicepatide in people with obesity or overweight

GlobeNewswire, Inc.

fallback image
Nov. 17, 2026

Commit Biologics announces final close of $60 million seed financing to advance complement-powered immune engagers toward the clinic

GlobeNewswire, Inc.

fallback image
Nov. 13, 2026

Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

fallback image
Nov. 9, 2026

PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD

GlobeNewswire, Inc.

fallback image
Nov. 12, 2026

Ascendis Pharma Reports Third Quarter 2026 Financial Results

GlobeNewswire, Inc.

fallback image
Nov. 12, 2026

Zealand Pharma Announces Financial Results for the First Nine Months of 2026

GlobeNewswire, Inc.

fallback image
Nov. 11, 2026

A New Hampshire Airman's journey through military medicine

DVIDS - Georgia

fallback image
Nov. 10, 2026

Ascendis Pharma to Participate in the Jefferies London Healthcare Conference

GlobeNewswire, Inc.

fallback image
Nov. 9, 2026

Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits

GlobeNewswire, Inc.

fallback image
Nov. 9, 2026

Zealand Pharma to participate in the Jefferies Global Healthcare Conference

GlobeNewswire, Inc.

fallback image
Nov. 9, 2026

Transgene Reports Continued Clinical Progress and Q3 2026 Financial Update

GlobeNewswire, Inc.

fallback image
Nov. 5, 2026

Eton Pharmaceuticals Announces Preliminary ET-700 Pilot Study Results Evaluating Copper Absorption Inhibition and Gastrointestinal Tolerability

GlobeNewswire, Inc.

fallback image
Nov. 5, 2026

Zealand Pharma conference call on Nov 12 at 2pm CET (8am ET) to present third quarter 2026 financial results

GlobeNewswire, Inc.

fallback image
Nov. 5, 2026

Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates

GlobeNewswire, Inc.

fallback image
Nov. 4, 2026

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition

GlobeNewswire, Inc.

fallback image
Nov. 5, 2026

ESO Appoints Three Associate Chief Medical Officers Across EMS, Education and Trauma

GlobeNewswire, Inc.

fallback image
Nov. 19, 2026

Evaxion announces strategy and business update and third quarter 2026 financial results

GlobeNewswire, Inc.

fallback image
Nov. 3, 2026

Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion

GlobeNewswire, Inc.

fallback image
Oct. 30, 2026

Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

GlobeNewswire, Inc.

Sign up for:

Healthcare Times Denmark

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: